Vaccination

Pfizer says COVID booster shot 95.6% effective

A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.

Vaccination

3 doses of Pfizer–BioNTech COVID vaccine better than 2

A Kaiser Permanente study published Feb. 14, 2022, in The Lancet Regional Health-Americas found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine conferred higher effectiveness against infection and ...

Vaccination

Israel tightens COVID 'green pass' rules, sparking protest

Israel restricted its COVID Green Pass on Sunday to allow only those who have received a vaccine booster dose or recently recuperated from coronavirus to enter indoor venues. The new criteria mean that nearly 2 million people ...

Vaccination

Israel to begin COVID booster shots for over 40s

Israelis aged 40 and over will be able to receive coronavirus vaccine booster shots starting this weekend, Health Minister Nitzan Horowitz said Thursday, as the country battles a spike in infections.

Pediatrics

Pfizer asks FDA to OK COVID-19 vaccine for under 5s

Pfizer Inc. said Wednesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine in children younger than the age of 5 years.

Vaccination

The difference between COVID-19 'third doses' and 'boosters'

As hospitalizations surge nationwide due to unvaccinated patients with COVID-19, vaccines are a crucial tool to prevent severe disease and overwhelmed hospital systems. More than 378 million doses of COVID-19 vaccine have ...

page 4 from 7